Frydman R B, Tomaro M L, Awruch J, Frydman B
Biochim Biophys Acta. 1983 Sep 13;759(3):257-63. doi: 10.1016/0304-4165(83)90321-5.
Rat liver biliverdin reductase exists in two molecular forms. The major molecular form 1 has a high reduction rate for biliverdin IX alpha, while the minor molecular from 2 has high reduction rates for both biliverdins IX alpha and IX beta. The major molecular form 1 was gradually transformed into a second major form (form 3) by treatment of the rats with CoCl2. Form 1 reduces biliverdin IX alpha at two and a half times the rate of biliverdin IX beta while form 3 reduces both isomers at about the same rate. This transformation involves a de novo mRNA and protein synthesis since it could be prevented by cycloheximide and actinomycin D. Molecular form 3 can be transformed back into molecular form 1 by an in vitro treatment with reduced thioredoxin. Phenylhydrazine treatment also induced the transformation of molecular form 1 into molecular form 3 in rat liver. Biliverdin reductase from rat spleen and kidney exists only in molecular form 1 and is not transformed into molecular form 3 by either CoCl2 or phenylhydrazine treatments.
大鼠肝脏胆绿素还原酶存在两种分子形式。主要的分子形式1对胆绿素IXα具有较高的还原速率,而次要的分子形式2对胆绿素IXα和IXβ均具有较高的还原速率。通过用CoCl₂处理大鼠,主要的分子形式1逐渐转变为第二种主要形式(形式3)。形式1还原胆绿素IXα的速率是胆绿素IXβ的两倍半,而形式3以大致相同的速率还原这两种异构体。这种转变涉及从头开始的mRNA和蛋白质合成,因为它可以被环己酰亚胺和放线菌素D阻止。通过用还原型硫氧还蛋白进行体外处理,分子形式3可以转变回分子形式1。苯肼处理也诱导大鼠肝脏中分子形式1向分子形式3的转变。大鼠脾脏和肾脏中的胆绿素还原酶仅以分子形式1存在,并且通过CoCl₂或苯肼处理都不会转变为分子形式3。